| Product Code: ETC7903743 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Latvia continued to see a significant influx of Acyclovir import shipments, with top exporting countries being Ukraine, Netherlands, India, China, and Germany. The high concentration of these imports indicates a competitive market landscape. The compound annual growth rate (CAGR) from 2020 to 2024 was an impressive 50.07%, showcasing a robust demand for Acyclovir in Latvia. Furthermore, the growth rate from 2023 to 2024 stood at 34.18%, underscoring the sustained momentum in the market. These trends suggest a lucrative opportunity for stakeholders in the Acyclovir import industry targeting Latvia.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Acyclovir Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Acyclovir Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Acyclovir Market - Industry Life Cycle |
3.4 Latvia Acyclovir Market - Porter's Five Forces |
3.5 Latvia Acyclovir Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Latvia Acyclovir Market Revenues & Volume Share, By Mechanism Of Action, 2021 & 2031F |
3.7 Latvia Acyclovir Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Latvia Acyclovir Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of herpes simplex virus infections in Latvia |
4.2.2 Growing awareness about the benefits of acyclovir in treating herpes infections |
4.2.3 Rising demand for antiviral medications in the healthcare sector of Latvia |
4.3 Market Restraints |
4.3.1 High competition from other antiviral drugs in the market |
4.3.2 Stringent regulations and approval processes for pharmaceutical products in Latvia |
5 Latvia Acyclovir Market Trends |
6 Latvia Acyclovir Market, By Types |
6.1 Latvia Acyclovir Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Acyclovir Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Latvia Acyclovir Market Revenues & Volume, By Herpes Simplex Virus Type I, 2021- 2031F |
6.1.4 Latvia Acyclovir Market Revenues & Volume, By Herpes Simplex Virus Type II, 2021- 2031F |
6.1.5 Latvia Acyclovir Market Revenues & Volume, By Varicella Zoster Virus, 2021- 2031F |
6.1.6 Latvia Acyclovir Market Revenues & Volume, By Epstein-Barr Virus, 2021- 2031F |
6.1.7 Latvia Acyclovir Market Revenues & Volume, By Cytomegalovirus, 2021- 2031F |
6.2 Latvia Acyclovir Market, By Mechanism Of Action |
6.2.1 Overview and Analysis |
6.2.2 Latvia Acyclovir Market Revenues & Volume, By Nucleotide Polymerase Inhibitors, 2021- 2031F |
6.2.3 Latvia Acyclovir Market Revenues & Volume, By Reverse Transcriptase Inhibitors, 2021- 2031F |
6.2.4 Latvia Acyclovir Market Revenues & Volume, By Protease Inhibitors, 2021- 2031F |
6.2.5 Latvia Acyclovir Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Latvia Acyclovir Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Latvia Acyclovir Market Revenues & Volume, By HIV, 2021- 2031F |
6.3.3 Latvia Acyclovir Market Revenues & Volume, By Hepatitis, 2021- 2031F |
6.3.4 Latvia Acyclovir Market Revenues & Volume, By Herpes Simplex Virus, 2021- 2031F |
6.3.5 Latvia Acyclovir Market Revenues & Volume, By Influenza, 2021- 2031F |
6.3.6 Latvia Acyclovir Market Revenues & Volume, By Others, 2021- 2031F |
7 Latvia Acyclovir Market Import-Export Trade Statistics |
7.1 Latvia Acyclovir Market Export to Major Countries |
7.2 Latvia Acyclovir Market Imports from Major Countries |
8 Latvia Acyclovir Market Key Performance Indicators |
8.1 Number of prescriptions for acyclovir in Latvia |
8.2 Rate of adoption of acyclovir in different healthcare facilities |
8.3 Patient satisfaction and feedback on the effectiveness of acyclovir in treating herpes infections |
9 Latvia Acyclovir Market - Opportunity Assessment |
9.1 Latvia Acyclovir Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Latvia Acyclovir Market Opportunity Assessment, By Mechanism Of Action, 2021 & 2031F |
9.3 Latvia Acyclovir Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Latvia Acyclovir Market - Competitive Landscape |
10.1 Latvia Acyclovir Market Revenue Share, By Companies, 2024 |
10.2 Latvia Acyclovir Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here